🇺🇸 FDA
Patent

US 9403911

Compositions and methods for detection and treatment of cancer

granted A61KA61K49/00

Quick answer

US patent 9403911 (Compositions and methods for detection and treatment of cancer) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K49/00